⨯

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

Robust growth, pipeline progress, and cash position

Companies: Allergy Therapeutics plc

Avacta Group PLC boss sees a huge opportunity with new version of cancer treatment

Companies: Avacta Group PLC

Morning Note – 13 January 2021

Companies: Allergy Therapeutics plc

Open Orphan present at the Proactive One2one virtual investment forum

Companies: Open Orphan Plc

Allergy Therapeutics - Positive 6-month trading update with strong cashflow

Companies: Allergy Therapeutics plc

Copyright © 2021 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top